Addition of Angiotensin Receptor Blockade or Mineralocorticoid Antagonism to Maximal Angiotensin-Converting Enzyme Inhibition in Diabetic Nephropathy

Journal of the American Society of Nephrology : JASN - United States
doi 10.1681/asn.2009070737
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Nephrology (ASN)

Related search

Angiotensin Converting Enzyme Inhibitors and Diabetic Nephropathy.

BMJ
1992English

Characterization of Renal Angiotensin-Converting Enzyme 2 in Diabetic Nephropathy

Hypertension
Internal Medicine
2003English

Addition of Cyclic Angiotensin-(1-7) to Angiotensin Converting Enzyme Inhibitor Therapy Has a Positive Add-On Effect in Experimental Diabetic Nephropathy.

Kidney International
Nephrology
2019English

Mineralocorticoid and Angiotensin Receptor Antagonism During Hyperaldosteronemia

Hypertension
Internal Medicine
2002English

Beneficial Effects of Angiotensin Converting Enzyme Inhibition on Renal Function in Patients With Diabetic Nephropathy.

BMJ
1986English

Angiotensin-I Converting Enzyme Polymorphism and Diabetic Nephropathy in North India

International Journal of Human Genetics
Genetics
2005English

Angiotensin-Converting Enzyme Inhibitors Versus Angiotensin Receptor Blockers

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System
Internal MedicineEndocrinology
2006English

Dual Blockade of the Renin-Angiotensin System With Angiotensin Converting Enzyme (ACE) Inhibitors and Angiotensin Receptor Blockers (ARBs)

British Journal of Clinical Pharmacology
Pharmacology
2011English

Cough and Angiotensin Converting Enzyme Inhibition

BMJ
1988English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy